WEEKLY BORTEZOMIB FOR THE TREATMENT OF STEROID REFRACTORY CHRONIC GRAFT-VERSUS-HOST DISEASE (CGVHD)

被引：1
|
作者：
Miller, A. M. [1 ]
Schneider, R. [1 ]
Agura, E. A. [1 ]
Vance, E. [1 ]
Bergman, R. B. [1 ]
Fay, J. [1 ]
Pineiro, L. [1 ]
Powell, S. [1 ]
Ovcina, Tadic M. [1 ]
Sampson, C. A. [1 ]
机构：
[1] Baylor Charles A Sammons Canc Ctr, Dallas, TX USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2011年 / 17卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2010.12.567
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
530
引用
收藏
页码：S343 / S343
页数：1
相关论文
共 50 条
  • [31] Sirolimus for treatment of steroid-refractory acute graft-versus-host disease
    Hoda, D.
    Pidala, J.
    Salgado-Vila, N.
    Kim, J.
    Perkins, J.
    Bookout, R.
    Field, T.
    Perez, L.
    Ayala, E.
    Ochoa-Bayona, J. L.
    Raychaudhuri, J.
    Alsina, M.
    Greene, J.
    Janssen, W.
    Fernandez, H. F.
    Anasetti, C.
    Kharfan-Dabaja, M. A.
    BONE MARROW TRANSPLANTATION, 2010, 45 (08) : 1347 - 1351
  • [32] Alemtuzumab in the treatment of steroid refractory acute Graft-versus-Host Disease.
    Gomez-Almaguer, David
    Ruiz-Arguelles, Guillermo
    Gonzalez-Llano, Oscar
    Cantu, Olga G.
    Gutierrez, Cesar H.
    Jaime-Perez, Jose Carlos
    Tarin-Arzaga, Luz
    Giralt, Sergio
    BLOOD, 2006, 108 (11) : 415B - 416B
  • [33] Treatment and Nursing for Steroid-Refractory Acute Graft-Versus-Host Disease
    Cazeau, Naomi
    Rodriguez, Stephany L.
    CLINICAL JOURNAL OF ONCOLOGY NURSING, 2023, 27 (04) : 397 - 403
  • [34] Sirolimus for treatment of steroid-refractory acute graft-versus-host disease
    D Hoda
    J Pidala
    N Salgado-Vila
    J Kim
    J Perkins
    R Bookout
    T Field
    L Perez
    E Ayala
    J L Ochoa-Bayona
    J Raychaudhuri
    M Alsina
    J Greene
    W Janssen
    H F Fernandez
    C Anasetti
    M A Kharfan-Dabaja
    Bone Marrow Transplantation, 2010, 45 : 1347 - 1351
  • [35] Alemtuzumab for the treatment of steroid-refractory acute graft-versus-host disease
    Gomez-Almaguer, David
    Ruiz-Arguelles, Guillenmo J.
    Tarin-Arzaga, Luz del Carmen
    Gonzalez-Llano, Oscar
    Gutierrez-Aguirre, Homero
    Cantu-Rodriguez, Olga
    Jaime-Perez, Jose
    Carrasco-Yalan, Antonio
    Giralt, Sergio
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (01) : 10 - 15
  • [36] BORTEZOMIB FOR STEROID REFRACTORY ACUTE GRAFT VERSUS HOST DISEASE (GVHD)
    Wagner, J. L.
    Mookajee, B.
    Filicko-O'Hara, J. E.
    Grosso, D. A.
    Flomenberg, N.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (02) : S370 - S370
  • [37] Improving treatment of refractory chronic extensive graft-versus-host disease
    Elez, M.
    Stamatovic, D.
    Tukic, L.
    Tarabar, O.
    Balint, B.
    Skuletic, V.
    Tasic, O.
    Simic, L.
    Malesevic, M.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S413 - S414
  • [38] Efficiency and Toxicity of Ruxolitinib as a Salvage Treatment for Steroid-Refractory Chronic Graft-Versus-Host Disease
    Wang, Dong
    Liu, Yin
    Lai, Xiaoxuan
    Chen, Jia
    Cheng, Qiao
    Ma, Xiao
    Lin, Zhihong
    Wu, Depei
    Xu, Yang
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [39] Treatment of chronic steroid-refractory graft-versus-host disease with low-dose rituximab
    von Bonin, Malte
    Oelschlaegel, Uta
    Radke, Joergen
    Stewart, Michelle
    Ehninger, Gerhard
    Bornhauser, Martin
    Platzbecker, Uwe
    TRANSPLANTATION, 2008, 86 (06) : 875 - 879
  • [40] STEROID DEPENDENT GRAFT-VERSUS-HOST-DISEASE MANAGED WITH WEEKLY BORTEZOMIB
    Alperstein, Warren
    Andreansky, Martin
    Ziga, Edward
    PEDIATRIC BLOOD & CANCER, 2018, 65
12345